Species Distribution and Antifungal Susceptibility Profile of Dermatophytes from a Tertiary Care Centre in North India

Abstract Objective  Dermatophytoses, one of the most ancient diseases, is becoming a menace in recent times. This has made the knowledge of antifungal susceptibility a priority in today's times. Material and Methods  This is a prospective study conducted over 18 months including all dermatophytes isolated during the period. Dermatophytes were identified by routine phenotypic methods. Antifungal susceptibility testing was performed for griseofulvin, terbinafine, and itraconazole as per the Clinical Laboratory Standard Institute M38 A2, and minimum inhibitory concentrations (MICs) were read after 5 days. Results  Patient details and associated risk factors were recorded. Fixed dose combinations with steroids were associated with 79.3% (46 out of 58) of patients with dermatophytosis of skin. Among the 72 dermatophytes isolated during the study period, 58 (80.5%) were isolated from skin scrapings and 14 (19.4%) from nail samples. Tinea corporis with cruris was the most common presentation. The most common dermatophyte isolated from skin scrapings was Trichophyton mentagrophytes complex (70.6%, 41 out of 58), while from nail samples it was Trichophyton rubrum complex (78.57%, 11 out of 14). Based on the MIC 50 and MIC 90 results, itraconazole showed the lowest MICs, followed by terbinafine and then griseofulvin. Conclusion  With the changing epidemiology of species distribution and antifungal resistance, there is a need for continuous surveillance of these parameters of dermatophytes.

[1]  Priya Uppuluri,et al.  A Study of In vitro Antifungal Susceptibility Patterns of Dermatophytic Fungi at a Tertiary Care Center in Western India , 2019, Indian journal of dermatology.

[2]  U. Saikia,et al.  A prospective study of the epidemiological and clinical patterns of recurrent dermatophytosis at a tertiary care hospital in India , 2018, Indian journal of dermatology, venereology and leprology.

[3]  A. Bitew Dermatophytosis: Prevalence of Dermatophytes and Non-Dermatophyte Fungi from Patients Attending Arsho Advanced Medical Laboratory, Addis Ababa, Ethiopia , 2018, Dermatology research and practice.

[4]  V. Pai,et al.  Antifungal Resistance in Dermatology , 2018, Indian journal of dermatology.

[5]  Smital Kulkarni,et al.  In vitro susceptibility testing of four antifungal drugs against fungal isolates in onychomycosis , 2018, International Journal of Research in Medical Sciences.

[6]  Z. Salehi,et al.  Antifungal drug susceptibility profile of clinically important dermatophytes and determination of point mutations in terbinafine-resistant isolates , 2018, European Journal of Clinical Microbiology & Infectious Diseases.

[7]  Ayşe Barış,et al.  In vitro susceptibility of seven antifungal agents against dermatophytes isolated in İstanbul , 2018, Turkish journal of medical sciences.

[8]  S. Dogra,et al.  Newer Topical Treatments in Skin and Nail Dermatophyte Infections , 2018, Indian dermatology online journal.

[9]  Ashutosh Kumar Singh,et al.  High terbinafine resistance in Trichophyton interdigitale isolates in Delhi, India harbouring mutations in the squalene epoxidase gene , 2018, Mycoses.

[10]  Saurabh Sharma,et al.  Antifungal susceptibility pattern of dermatomycosis in a tertiary care hospital of North India , 2018 .

[11]  S. Dogra,et al.  Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance , 2018, Antimicrobial Agents and Chemotherapy.

[12]  P. Arora,et al.  Is Antifungal Resistance a Cause for Treatment Failure in Dermatophytosis: A Study Focused on Tinea Corporis and Cruris from a Tertiary Centre? , 2018, Indian dermatology online journal.

[13]  Rekha Sharma,et al.  Recurrent dermatophytosis: A rising problem in Sikkim, a Himalayan state of India , 2017, Indian journal of pathology & microbiology.

[14]  S. Dogra,et al.  Treatment of Dermatophytosis in Elderly, Children, and Pregnant Women , 2017, Indian dermatology online journal.

[15]  Thai D. Nguyen,et al.  Distribution of Species of Dermatophyte Among Patients at a Dermatology Centre of Nghean Province, Vietnam, 2015–2016 , 2017, Mycopathologia.

[16]  M. Mokni,et al.  Prevalence, Etiology, and Risk Factors of Tinea Pedis and Tinea Unguium in Tunisia , 2017, The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale.

[17]  S. Verma,et al.  The Great Indian Epidemic of Superficial Dermatophytosis: An Appraisal , 2017, Indian journal of dermatology.

[18]  Gagandeep Singh,et al.  Molecular Identification and Antifungal Susceptibility Patterns of Clinical Dermatophytes Following CLSI and EUCAST Guidelines , 2017, Journal of fungi.

[19]  A. Inamadar,et al.  Clinical failure of antifungal therapy of dermatophytoses: Recurrence, resistance, and remedy , 2017 .

[20]  A. Kindo,et al.  Incidence and prevalence of dermatophytosis in and around Chennai, Tamilnadu, India , 2016 .

[21]  A. Sahoo,et al.  Management of tinea corporis, tinea cruris, and tinea pedis: A comprehensive review , 2016, Indian dermatology online journal.

[22]  H. Badali,et al.  Molecular Characterization and In Vitro Antifungal Susceptibility of 316 Clinical Isolates of Dermatophytes in Iran , 2016, Mycopathologia.

[23]  P. Sharma,et al.  Determination of minimum inhibitory concentrations of itraconazole, terbinafine and ketoconazole against dermatophyte species by broth microdilution method , 2015, Indian journal of medical microbiology.

[24]  Lakshmi Vasantha Poluri,et al.  Clinicomycological Study of Dermatophytosis in South India , 2015, Journal of laboratory physicians.

[25]  H. Badali,et al.  In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs , 2015, Mycoses.

[26]  S. Seyedmousavi,et al.  Comparison of the In Vitro Activities of Newer Triazoles and Established Antifungal Agents against Trichophyton rubrum , 2015, Antimicrobial Agents and Chemotherapy.

[27]  A. Lakshmanan,et al.  Epidemiological and clinical pattern of dermatomycoses in rural India , 2015, Indian journal of medical microbiology.

[28]  N. L. Sharma,et al.  Mycological Pattern of Dermatophytosis in and Around Shimla Hills , 2014, Indian journal of dermatology.

[29]  R. Boloor,et al.  A Clinical and Mycological Study of Dermatophytic Infections , 2014, Indian journal of dermatology.

[30]  P. Sharma,et al.  Epidemiological studies on Dermatophytosis in human patients in Himachal Pradesh, India , 2014, SpringerPlus.

[31]  Y. Bulut,et al.  In vitro activities of antifungal drugs against dermatophytes isolated in Tokat, Turkey , 2013, International journal of dermatology.

[32]  S. Hashemi,et al.  In-vitro Activity of 10 Antifungal Agents against 320 Dermatophyte Strains Using Microdilution Method in Tehran , 2013, Iranian journal of pharmaceutical research : IJPR.

[33]  Roberto Arenas,et al.  Tinea incognito. , 2010, Clinics in dermatology.

[34]  Maria R R Silva,et al.  In vitro susceptibility testing of dermatophytes isolated in Goiania, Brazil, against five antifungal agents by broth microdilution method. , 2009, Revista do Instituto de Medicina Tropical de Sao Paulo.

[35]  M. Pihet,et al.  Conventional Methods for the Diagnosis of Dermatophytosis , 2008, Mycopathologia.

[36]  Clinical,et al.  Reference method for broth dilution antifungal susceptibility testing of filamentous fungi : Approved standard , 2008 .

[37]  Aditya K. Gupta,et al.  In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity , 2003, The British journal of dermatology.

[38]  H. Zaun,et al.  Treatment of toenail onychomycosis. A randomized, double-blind study with terbinafine and griseofulvin. LAGOS II Study Group. , 1995, Archives of dermatology.